MED Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

11.510

Open

11.050

VWAP

11.00

Vol

298.00K

Mkt Cap

122.00M

Low

10.950

Amount

3.00M

EV/EBITDA(TTM)

-6.00

Total Shares

11.00M

EV

-51.00M

EV/OCF(TTM)

-7.00

P/S(TTM)

0.00

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

Show More

Events Timeline

(ET)

2026-01-05

09:20:00

Medifast CEO Dan Chard to Step Down in June

2025-11-03 (ET)

2025-11-03

16:13:09

Medifast Reports Q4 EPS of $1.25, Exceeding Estimate of 45 Cents by 70 Cents

2025-11-03

16:12:15

Medifast Announces Q3 Earnings Per Share of 21 Cents, Below Estimate of 36 Cents

2025-08-04 (ET)

2025-08-04

16:16:02

Medifast sees Q2 EPS (60c)-0c, one estimate (30c)

2025-08-04

16:15:15

Medifast reports Q2 EPS 22c vs. (75c) last year

2025-04-28 (ET)

2025-04-28

16:16:44

Medifast sees Q2 EPS (55c)-0c, one estimate (7c)

2025-04-28

16:15:46

Medifast reports Q1 EPS (7c) vs. 76c last year

News

an image of PRnewswire

01-19PRnewswire

Doseology Sciences Partners with McKinney to Enhance Regulatory Compliance

an image of Newsfilter

01-19Newsfilter

Doseology Sciences Partners with McKinney to Enhance Regulatory Compliance

an image of Newsfilter

01-16Newsfilter

Medifast's OPTAVIA Program Transforms Health, Clients Lose 10 Times More Weight

an image of NASDAQ.COM

2025-11-05NASDAQ.COM

Significant Wednesday Options Trading: RKLB, EAT, MED

an image of Newsfilter

2025-10-27Newsfilter

Medifast Unveils Strategic Transition to Focus on Metabolic Health with Launch of Metabolic Synchronization™

an image of Newsfilter

2025-10-21Newsfilter

Medifast to Release Third Quarter Financial Results for the Period Ending September 30, 2025

Valuation Metrics

The current forward P/E ratio for Medifast Inc (MED.N) is -6.15, compared to its 5-year average forward P/E of 10.92. For a more detailed relative valuation and DCF analysis to assess Medifast Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

N/A

5Y Average PE

10.92

Current PE

-6.15

Overvalued PE

77.40

Undervalued PE

-55.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

5Y Average EV/EBITDA

6.73

Current EV/EBITDA

4.35

Overvalued EV/EBITDA

10.52

Undervalued EV/EBITDA

2.95

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

5Y Average PS

0.94

Current PS

0.32

Overvalued PS

1.48

Undervalued PS

0.40

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

rerun right now to see if the list changes

Intellectia · 29 candidates

Price: $3.00 - $100.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEOne Day Rise Prob: >= 60One Day Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

Sidus Space Inc

235.00M

Digital Brands Group Inc (Pre-Reincorporation)

68.00M

Medifast Inc

129.00M

Advance Auto Parts Inc

3.00B

CMB.TECH NV

3.00B

Lisata Therapeutics Inc

36.00M

Whales Holding MED

Trading Trends

People Also Watch

Frequently Asked Questions

What is Medifast Inc (MED) stock price today?

The current price of MED is 11.44 USD — it has increased 2.6 % in the last trading day.

What is Medifast Inc (MED)'s business?

Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.

What is the price predicton of MED Stock?

Wall Street analysts forecast MED stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MED is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Medifast Inc (MED)'s revenue for the last quarter?

Medifast Inc revenue for the last quarter amounts to 89.00M USD, decreased -36.21 % YoY.

What is Medifast Inc (MED)'s earnings per share (EPS) for the last quarter?

Medifast Inc. EPS for the last quarter amounts to -0.21 USD, decreased -310.00 % YoY.

How many employees does Medifast Inc (MED). have?

Medifast Inc (MED) has 504 emplpoyees as of January 31 2026.

What is Medifast Inc (MED) market cap?

Today MED has the market capitalization of 122.00M USD.